Because in our system CD112/CD155 down-regulation correlated with reduced NK cell activation and reduced tumor cell killing, we next assessed whether signal activation through DNAM-1 is a key mediator for NK cell cytotoxicity against melanoma cells. The gene discussed is CD226; the disease is neoplasm.